First-trimester serum PAPP-A and fβ-hCG concentrations and other maternal characteristics to establish logistic regression-based predictive rules for adverse pregnancy outcome
Article first published online: 8 SEP 2010
Copyright © 2010 John Wiley & Sons, Ltd.
Special Issue: 1st Trimester Screening and Diagnosis
Volume 31, Issue 1, pages 50–57, January 2011
How to Cite
van Ravenswaaij, R., Tesselaar-van der Goot, M., de Wolf, S., van Leeuwen-Spruijt, M., Visser, G. H. A. and Schielen, P. C. J. I. (2011), First-trimester serum PAPP-A and fβ-hCG concentrations and other maternal characteristics to establish logistic regression-based predictive rules for adverse pregnancy outcome. Prenat. Diagn., 31: 50–57. doi: 10.1002/pd.2610
- Issue published online: 5 JAN 2011
- Article first published online: 8 SEP 2010
- Manuscript Accepted: 24 JUL 2010
- Manuscript Revised: 16 JUL 2010
- Manuscript Received: 29 APR 2010
- 2000. Perinatal complications associated with maternal tobacco use. Semin Neonatol 5(3): 231–241. , .
- 2001. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health 91(3): 436–440. , , .
- 2005. Association between maternal smoking and low birth weight in Switzerland: the EDEN study. Swiss Med Wkly 135(35–36): 525–530. , , .
- FASTER Consortium. 2005. Impact of maternal age on obstetric outcome. Obstet Gynecol 105(5Pt1): 983–990. , , , et al.
- 1998. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 338(3): 147–152. , , , .
- 2003. Frequency and clinical consequences of extremely high maternal serum PAPP-A levels. Prenat Diagn 23(5): 385–388. , , , et al.
- 2004. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 191(4): 1446–1451. , , , et al.
- 2004. Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss. Obstet Gynecol 104(1): 30–36. , , , et al.
- First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. 2004. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 191(4): 1452–1458. , , , et al.
- 2008. Lack of standardization in determining gestational age for prenatal screening. Ultrasound Obstet Gynecol 32(5): 607–611. , , , et al.
- 2006. First-trimester maternal dried blood Down syndrome screening marker levels in early pregnancy loss. Prenat Diagn 26(12): 1137–1141. , , , , .
- 2005. Pre-pregnancy weight and the risk of stillbirth and neonatal death. BJOG 112(4): 403–408. , , , , .
- 2004. Pregnancy outcomes in unselected singleton pregnant women with an increased risk of first-trimester Down syndrome. Acta Obstet Gynecol Scand 83(12): 1130–1134. , , , et al.
- 1999. An investigation of social and class differences in very-low birth weight outcomes: a continuing public health concern. J Health Care Finance 25(3): 75–89. , ,
- 1998. Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery. Prenat Diagn 18(2): 147–152. , , , et al.
- 2006. The efficacy of first-trimester PAPP-A and free beta hCG levels for predicting adverse pregnancy outcome. J Perinat Med 34(2): 145–148. , , .
- 2000. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 107(10): 1265–1270. , , .
- 2009. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 33: 23–33. , , .
- 2008. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol 199(2): 122.e1–122.e11. , , , et al.
- 2003. Prepregnancy weight and adverse perinatal outcomes in an ethnically diverse population. Obstet Gynecol 102(5Pt1): 1022–1027. , , , , et al..
- Standpoint prenatal screening (2). July 2004. URL: http://www.minvws.nl/images/IBE-2488853A_tcm19-102032.pdf. [02 July 2007]. .
- 2005. Maternal race/ethnicity and predictors of pregnancy and infant outcomes. Biol Res Nurs 7(1): 55–66. , , .
- 2004. First-trimester placentation and the risk of antepartum stillbirth. JAMA 292(18): 2249–2254. , , , et al.
- 2006. Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol 107(1): 161–166. , , , et al.
- 2002. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, preterm birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 87(4): 1762–1777. , , .
- 2008. ADAM12s in maternal serum as a potential marker of pre-eclampsia. Prenatal diagn 28(3): 212–216. , .
- 2005. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn 25(10): 949–953. , , , ,
- 2003. Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A. Prenat Diagn 23(12): 990–996. , , .
- 2002. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn 22(9): 778–782. , , .